Elucidating the exact pharmacological mechanism of action (MOA) of naturally developing compounds is usually challenging. Despite the fact that Tarselli et al. (60) developed the first de novo synthetic pathway to conolidine and showcased this naturally developing compound effectively suppresses responses to the two chemically induced and inflammat… Read More